Prostate Cancer Prevention

Inbunden, Engelska, 2014

1 459 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely.

Produktinformation

Utgivningsdatum2014-03-03
Mått155 x 235 x 17 mm
Vikt448 g
FormatInbunden
SpråkEngelska
SerieRecent Results in Cancer Research
Antal sidor169
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783642451942

Tillhör följande kategorier

Onkologi inom Medicin
Urologi inom Medicin

Biology and natural history of prostate cancer.- Nutrition and prostate cancer.- Prostate cancer chemoprevention.- Lifestyle and dietary factors.- GWAS in prostate cancer predisposition and application to screening and prevention.- Risk prediction biomarkers – CCP.- Risk prediction biomarkers - TMPRSS2-ERG.- Risk prediction biomarkers – PCA3.- Risk adapted chemoprevention for PCa.- Outlook for 5α reductase inhibitors in prostate cancer prevention.- Prostate cancer chemoprevention: Aspirin.- Prostate cancer chemoprevention: DFMO.- Prostate cancer chemoprevention: Lycopene.- Distinguishing aggressive from indolent prostate cancer.- Prognosis and Management of low grade disease - Management of Gleason 6.- Prostate cancer prevention: Policy & Research implications.

From the reviews: "Part of the Recent Advances in Cancer Research series, this book's title suggests that it tackles prevention of prostate cancer. ... scientists and clinicians who deal with prostate cancer are the main audience. ... The discussion of agent development and strategies is very useful to anyone looking to tackle the challenging area of prostate cancer chemoprevention." (Leonard G. Gomella, Doody's Book Reviews, May, 2014)